Table 1.
Distribution of lesions in Development and Validation datasets, based on expert clinical diagnosis or histology where available
| Diagnosis | Development dataset | % | UK validation dataset | % | Australian validation dataset | % |
|---|---|---|---|---|---|---|
| Naevus | 293 | 69. 4% | 159 | 76. 4% | 333 | 57. 3% |
| Seborrhoeic keratosis | 101 | 23. 9% | 39 | 18. 7% | 128 | 22. 0% |
| Solar lentigo | 0 | 0 | 0 | 0 | 67 | 11. 5% |
| Basal cell carcinoma | 0 | 0 | 0 | 0 | 22 | 3. 8% |
| Melanoma | 3 | 0.7% | 2 | 1. 0% | 7 | 1. 2% |
| Angiokeratoma | 0 | 0.0% | 0 | 0.0% | 6 | 1. 0% |
| Dermatofibroma | 14 | 3. 3% | 6 | 2. 9% | 5 | 0.9% |
| Lentigo maligna | 0 | 0.0% | 0 | 0.0% | 4 | 0.7% |
| Haemangioma | 11 | 2. 6% | 2 | 1. 0% | 0 | 0.0% |
| Lentigo simplex | 0 | 0.0% | 0 | 0.0% | 5 | 0.9% |
| Ephilis | 0 | 0.0% | 0 | 0.0% | 3 | 0.3% |
| Papilloma | 0 | 0.0% | 0 | 0.0% | 1 | 0.2% |
| Total | 422 | 208 | 581 | |||